• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Model Number 1973-01
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Vascular Dissection (3160)
Event Date 11/16/2017
Event Type  Injury  
Event Description
Ranger ii sfa.It was reported that a dissection occurred.The subject was enrolled into ranger ii sfa study on (b)(6) 2017 and the index procedure was performed on the same day.The 100% stenosed target lesion was located in the left superficial femoral artery (sfa) with a reference vessel diameter of 5.5 mm and a length of 125 mm.It was classified as a tasc ii b lesion.The target lesion was treated with pre-dilatation using 4 mm x 150 mm balloon.Following this, a grade c dissection was noted, which was treated with balloon dilatation, and the complication was resolved.Then, the target lesion was treated with 6 x 100 mm and 6 x 80 mm ranger study balloons.Following this intervention, grade c dissection was noted again for which balloon dilatation was performed.However, complication was not resolved.Post dilatation with 5 mm x 100 mm was performed, and grade c dissection was still noted, which was also treated with balloon dilatation however, complication was not resolved.On (b)(6) 2017, the subject was discharged on aspirin and clopidogrel.On (b)(6) 2018, 361 days post index procedure, the subject presented to the protocol scheduled 12 months follow up visit with the symptoms of moderate pain or discomfort in the left limb.The subject was diagnosed with stenosis in the left sfa.No action was taken to treat the event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER PACLITAXEL-COATED PTA BALLOON CATHETER
Type of Device
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key13042383
MDR Text Key282484276
Report Number2134265-2021-16011
Device Sequence Number1
Product Code ONU
Combination Product (y/n)Y
Reporter Country CodeCA
PMA/PMN Number
G160172
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/20/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/05/2018
Device Model Number1973-01
Device Catalogue Number1973-01
Device Lot Number1071H17
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/10/2021
Initial Date FDA Received12/20/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/06/2017
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age76 YR
Patient SexMale
Patient RaceWhite
-
-